Licensed oral vitamin B12 formulation for non-dietary related deficiency.

Low dose Combisal more cost effective than Seretide

Chlordiazepoxide is included for its use in acute alcohol withdrawal rather than for use in anxiety.

Chlordiazepoxide is included for its use in acute alcohol withdrawal rather than for use in anxiety.

Combivent® nebuliser solution should be started only by a Respiratory Physician. It is less expensive to prescribe salbutamol and ipratropium bromide nebuliser solutions separately but this requires patients to nebulise 4.5 mL instead of 2.5 mL.

Enstilar foam is accepted onto the formulary as another formulation of calcipotriol and betamethasone dipropionate for patients with non-scalp psoriasis. The recommended treatment period for foam (and Dovobet ointment) is 4 weeks. If it is necessary to continue or restart treatment after this period, treatment should be continued after medical review and under regular medical supervision. General measures such as the frequent use of emollients are important in the management of psoriasis. If using other topical products containing calcipotriol in addition to Enstilar, the total dose of all calcipotriol containing products should not exceed 15 g per day.

May only be initiated in primary care for people with type 2 diabetes and no heart failure.

May only be initiated in primary care for people with type 2 diabetes and no heart failure.

Cinacalcet is commissioned by NHS England for complex primary hyperparathyroidism in adults and secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy. There is a shared care guideline for use in primary hyperparathyroidism

Cinacalcet is commissioned by NHS England for complex primary hyperparathyroidism in adults and secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy. There is a shared care guideline for use in primary hyperparathyroidism

Cost-effective alternative to liquid preparations, where tablets cannot be crushed and dissolved. Please note use is off-label for children under 6 years.

Catephen (green tea leaf extract 10% ointment) is accepted onto the formulary as a specialist initiated drug for use in patients not suitable for podophyllotoxin or who have not responded to treatment with podophyllotoxin

Cinacalcet is commissioned by NHS England for complex primary hyperparathyroidism in adults and secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy. There is a shared care guideline for use in primary hyperparathyroidism